日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy of Neratinib-Based Therapy in ERBB2-Mutant Lung Adenocarcinomas: Findings From 2 International Phase 2 Studies

奈拉替尼治疗ERBB2突变型肺腺癌的疗效:两项国际II期研究的结果

Li, Bob T; Gandhi, Leena; Ravichandran, Vignesh; Besse, Benjamin; Mazières, Julien; Shapiro, Geoffrey I; Boni, Valentina; Waqar, Saiama N; Park, Haeseong; Quinn, David I; Martinez, Alejandro; Stemmer, Salomon M; Cortot, Alexis B; Barlesi, Fabrice; Quoix, Elisabeth; Burkard, Mark E; Selcuklu, S Duygu; Hunt, Casey; Donoghue, Mark T A; Kris, Mark G; Bebchuk, Judith; Eli, Lisa D; McCulloch, Leanne; Solit, David B; Jänne, Pasi A

Prolonging lung cancer response to EGFR inhibition by targeting the selective advantage of resistant cells

通过靶向耐药细胞的选择性优势来延长肺癌对 EGFR 抑制剂的反应时间

Brunet, Lisa; Alexandre, David; Lee, Jiyoung; Blanquer-Rosselló, Maria Del Mar; Bracquemond, David; Guernet, Alexis; Chhouri, Houssein; Goupil, Mathilde; Kherrouche, Zoulika; Arabo, Arnaud; Mancini, Maicol; Cartier, Dorthe; Yao, Shen; Godefroy, David; Dehedin, Julie; Li, Jian-Rong; Duparc, Céline; Jamme, Philippe; Vinchent, Audrey; Bérard, Caroline; Tulasne, David; Arena, Sabrina; Bardelli, Alberto; Cheng, Chao; Cho, Byoung Chul; Wurtz, Olivier; Coulouarn, Cédric; Maraver, Antonio; Aaronson, Stuart A; Cortot, Alexis B; Anouar, Youssef; Grumolato, Luca

MET variants with activating N-lobe mutations identified in hereditary papillary renal cell carcinomas still require ligand stimulation.

在遗传性乳头状肾细胞癌中发现的具有激活 N 叶突变的 MET 变体仍然需要配体刺激

Guérin Célia, Vinchent Audrey, Fernandes Marie, Damour Isabelle, Laratte Agathe, Tellier Rémi, Estevam Gabriella O, Meneboo Jean-Pascal, Villenet Céline, Descarpentries Clotilde, Fraser James S, Figeac Martin, Cortot Alexis B, Rouleau Etienne, Tulasne David

COMPOSIT study: evaluating osimertinib combination with targeted therapies in EGFR-mutated non-small cell lung cancer

COMPOSIT 研究:评估奥希替尼联合靶向疗法治疗 EGFR 突变型非小细胞肺癌

Mehlman, Camille; Swalduz, Aurelie; Monnet, Isabelle; Morin, Clara; Wislez, Marie; Guisier, Florian; Curcio, Hubert; Du Rusquec, Pauline; Cortot, Alexis B; Gounant, Valerie; Abbar, Baptiste; Duchemann, Boris; Giroux-Leprieur, Etienne; Pierret, Thomas; Quilot, Fleur-Marie; Cadranel, Jacques; Fallet, Vincent

Impact of corticosteroids on the efficacy of first-line pembrolizumab plus chemotherapy in patients with advanced non-small-cell lung cancer

皮质类固醇对一线帕博利珠单抗联合化疗治疗晚期非小细胞肺癌患者疗效的影响

Roboubi, Amytis; Wasielewski, Eric; Bordier, Soraya; Turlotte, Amélie; Pavaut, Geoffrey; Scherpereel, Arnaud; Cortot, Alexis; Gauvain, Clément

Pembrolizumab versus pembrolizumab plus chemotherapy in patients with PDL1 ⩾50% advanced non-small-cell lung cancer, depending on tumor aggressiveness and clinical impact

在PD-L1≥50%的晚期非小细胞肺癌患者中,帕博利珠单抗与帕博利珠单抗联合化疗的疗效比较,取决于肿瘤的侵袭性和临床影响。

Lejeune, Marine; Wasielewski, Eric; Leroy, Vincent; Bordier, Soraya; Scherpereel, Arnaud; Cortot, Alexis; Gauvain, Clément

Artificial sweeteners differentially activate sweet and bitter gustatory neurons in Drosophila.

人工甜味剂对果蝇的甜味和苦味味觉神经元具有不同的激活作用

Arntsen Christian, Grenon Jake, Chauvel Isabelle, Fraichard Stéphane, Dupas Stéphane, Cortot Jérôme, Audette Kayla, Musso Pierre-Yves, Stanley Molly

Patterns of Treatment and Real-World Outcomes of Patients With Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations Receiving Mobocertinib: The EXTRACT Study

接受莫博替尼治疗的EGFR 20号外显子插入突变非小细胞肺癌患者的治疗模式和真实世界结果:EXTRACT研究

Liu, Geoffrey; Nyaw, Shi Feng; Mok, Tony S K; Curcio, Hubert; Cortot, Alexis B; Kam, Tsz Yeung; Descourt, Renaud; Chik, Yin Kwan; Cheema, Parneet; Gwinnutt, James M; Churchill, Eric N; Nyborn, Justin; Curran, Eileen; Savell, Alexandra; Yin, Yu; Chong, Katie; Tanaka-Chambers, Yuka; Kretz, Julian; Cadranel, Jacques

Plain language summary of MARIPOSA-2: amivantamab-chemotherapy either with or without lazertinib for treatment of non-small-cell lung cancer

MARIPOSA-2 研究简明语言摘要:阿米伐他单抗联合化疗(可联合或不联合拉泽替尼)治疗非小细胞肺癌

Passaro, Antonio; Cortot, Alexis B; Gentzler, Ryan D; Reckamp, Karen L; Shah, Sujay; William, William Nassib; Cho, Byoung Chul

MOMENT registry: Patients with advanced non-small-cell lung cancer harboring MET exon 14 skipping treated with systemic therapy

MOMENT登记研究:接受全身治疗的携带MET外显子14跳跃突变的晚期非小细胞肺癌患者

Thomas, Michael; Christopoulos, Petros; Iams, Wade T; Mazières, Julien; Cortot, Alexis B; Peled, Nir; Minuti, Gabriele; Smit, Egbert F; Audhuy, Francois; Berghoff, Karin; Eggleton, S Peter; Fries, Frank; Hildenbrand, Maike; Liu, Peter; Mahmoudpour, Seyed Hamidreza; Menzel, Christoph; Oksen, Dina